IP Library Assignment 019600/0122
Patent Assignment
Reel/Frame 019600/0122

Assignment of Assignor's Interest

Recorded: 2007-07-24 Pages: 6
Assignors
NORONHA, GLENN
Executed: 2007-05-07
MAK, CHI CHING
Executed: 2007-05-07
CAO, JIANGUO
Executed: 2007-05-07
RENICK, JOEL
Executed: 2007-05-07
MCPHERSON, ANDREW
Executed: 2007-05-07
ZENG, BINQI
Executed: 2007-05-07
PATHAK, VED P.
Executed: 2007-05-07
LOHSE, DANIEL L.
Executed: 2007-05-07
HOOD, JOHN D.
Executed: 2007-05-07
SOLL, RICHARD M.
Executed: 2007-05-07
Assignee
TARGEGEN, INC.
9380 JUDICIAL DRIVE, SAN DIEGO, CALIFORNIA, 92121
Covered Property (1)
Bi-Aryl Meta-Pyrimidine Inhibitors of Kinases
Patent: 7,825,246 →
Application: 11/796,717 →
Publication: US 2007/0259904
Related Assignments (7)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 18, 2010
From: NORONHA, GLENN; MAK, CHI CHING; CAO, JIANGUO; RENICK, JOEL
To: TARGEGEN, INC.
Reel/Frame 025154/0893 →
Corrective Assignment to Correct the State of Incorporation from a California Corporation to a Delaware Corporation for the Assignee Previously Recorded on Reel 025154 Frame 0893. Assignor(S) Hereby Confirms the State of Incorporation for Targegen, Inc. to Be a Delaware Corporation. Jun 25, 2012
From: NORONHA, GLENN; MAK, CHI CHING; CAO, JIANGUO; RENICK, JOEL
To: TARGEGEN, INC.
Reel/Frame 028440/0123 →
Change of Name May 25, 2017
From: IMPACT THERAPEUTICS, INC.
To: IMPACT BIOMEDICINES, INC.
Reel/Frame 042586/0643 →
Assignment of Assignor's Interest May 25, 2017
From: TARGEGEN, INC.
To: IMPACT THERAPEUTICS, INC.
Reel/Frame 042512/0179 →
Security Interest Nov 30, 2017
From: IMPACT BIOMEDICINES, INC.
To: LIND SA, LLC, AS COLLATERAL AGENT
Reel/Frame 044572/0660 →
Release of Security Interest Feb 12, 2018
From: LIND SA LLC, AS COLLATERAL AGENT
To: IMPACT BIOMEDICINES, INC.
Reel/Frame 044904/0628 →
Corrective Assignment to Correct the Assignee's Name Previously Recorded at Reel: 042512 Frame: 0179. Assignor(S) Hereby Confirms the Assignment . Aug 21, 2019
From: TARGEGEN, INC.
To: IMPACT BIOMEDICINES, INC.
Reel/Frame 050297/0562 →